HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jong Oh Kim Selected Research

tanespimycin (17AAG)

8/2017Engineering of multifunctional temperature-sensitive liposomes for synergistic photothermal, photodynamic, and chemotherapeutic effects.
7/2017Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
6/2015Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.
1/2015Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jong Oh Kim Research Topics

Disease

110Neoplasms (Cancer)
03/2024 - 01/2009
17Breast Neoplasms (Breast Cancer)
01/2020 - 06/2015
13Wounds and Injuries (Trauma)
11/2022 - 07/2008
6Hyperthermia
01/2021 - 02/2017
6Colorectal Neoplasms (Colorectal Cancer)
06/2020 - 01/2016
5Lung Neoplasms (Lung Cancer)
03/2024 - 02/2017
4Inflammation (Inflammations)
01/2021 - 07/2014
4Prostatic Neoplasms (Prostate Cancer)
10/2019 - 07/2016
3Melanoma (Melanoma, Malignant)
10/2021 - 10/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 11/2017
3Hepatocellular Carcinoma (Hepatoma)
04/2017 - 09/2015
2Triple Negative Breast Neoplasms
01/2023 - 10/2021
2Colitis
01/2021 - 12/2019
2Body Weight (Weight, Body)
12/2020 - 01/2017
2Colonic Neoplasms (Colon Cancer)
08/2020 - 11/2017
2Neoplasm Metastasis (Metastasis)
01/2020 - 10/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2018 - 02/2017
2Pain (Aches)
01/2018 - 08/2005
2Necrosis
01/2018 - 10/2016

Drug/Important Bio-Agent (IBA)

18Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 06/2012
15PolymersIBA
04/2022 - 01/2009
12Peptides (Polypeptides)IBA
09/2023 - 05/2013
11LipidsIBA
01/2022 - 12/2015
10Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 04/2017
9Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2017
9HydrogelsIBA
04/2022 - 07/2008
9GoldIBA
10/2021 - 04/2017
9Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 - 08/2016
9Silicon Dioxide (Silica)FDA LinkGeneric
01/2021 - 01/2016
9Docetaxel (Taxotere)FDA Link
11/2017 - 08/2013
8graphene oxideIBA
08/2020 - 12/2015
8MicellesIBA
11/2017 - 01/2009
7Liposomes (Liposome)IBA
01/2024 - 05/2013
7Polyvinyl AlcoholIBA
04/2022 - 07/2008
7AlbuminsIBA
08/2021 - 08/2016
7Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 06/2017
6Caspase 3 (Caspase-3)IBA
01/2021 - 01/2015
6Irinotecan (Camptosar)FDA LinkGeneric
10/2018 - 06/2015
6AlginatesIBA
10/2016 - 07/2008
5VorinostatFDA Link
02/2021 - 08/2014
4Small Interfering RNA (siRNA)IBA
10/2021 - 10/2018
4AntigensIBA
10/2021 - 01/2018
4Photosensitizing Agents (Photosensitizers)IBA
01/2021 - 08/2017
4Hyaluronic Acid (Hyaluronan)IBA
12/2020 - 12/2014
4ChitosanIBA
01/2019 - 06/2010
4ArtesunateIBA
12/2017 - 01/2015
4tanespimycin (17AAG)IBA
08/2017 - 01/2015
3MicroRNAs (MicroRNA)IBA
10/2021 - 07/2018
3LigandsIBA
08/2021 - 10/2018
3Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 05/2017
3CopperIBA
12/2020 - 05/2019
3Sulfides (Thioethers)IBA
12/2020 - 05/2019
3titanium dioxide (Titania)FDA Link
08/2020 - 07/2018
3Imatinib Mesylate (Gleevec)FDA Link
08/2020 - 03/2017
3SolutionsIBA
05/2019 - 07/2014
3Transferrin (beta 2 Transferrin)IBA
04/2019 - 10/2017
3Bortezomib (Velcade)FDA Link
01/2019 - 01/2017
3celastrolIBA
10/2018 - 01/2016
3NanocapsulesIBA
03/2018 - 12/2015
3Colloids (Colloid)IBA
03/2016 - 05/2015
3Lipid NanoparticlesIBA
01/2016 - 08/2014
3Drug CombinationsIBA
01/2016 - 10/2014
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2016 - 01/2015
3Poloxamer (Poloxamer 407)IBA
12/2015 - 08/2005
3NanogelsIBA
06/2015 - 03/2011
3imidazole mustard (BIC)IBA
06/2015 - 06/2012
2AntibodiesIBA
03/2024 - 07/2019
2Messenger RNA (mRNA)IBA
03/2024 - 01/2022
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 01/2020
2Interferon Type IIBA
09/2023 - 01/2023
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2023 - 01/2019
2ChemokinesIBA
01/2023 - 10/2019
2Monoclonal AntibodiesIBA
01/2022 - 07/2017
2Imiquimod (Aldara)FDA LinkGeneric
10/2021 - 10/2019
2EnzymesIBA
10/2021 - 07/2018
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2021 - 10/2018
2cupric sulfide (CuS)IBA
12/2020 - 05/2019
2Immune Checkpoint InhibitorsIBA
10/2020 - 07/2019
2DisulfidesIBA
01/2020 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 08/2016
2Protein CIBA
01/2020 - 07/2018
2lonidamineIBA
01/2020 - 11/2017
2Apoptosis Regulatory ProteinsIBA
10/2019 - 01/2017
2ZeinIBA
10/2019 - 01/2017
2PalladiumIBA
04/2019 - 01/2018
2Phosphorus (Red Phosphorus)IBA
01/2019 - 10/2018
2SilverIBA
09/2018 - 05/2017
2Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2018 - 02/2017
2Antineoplastic Agents (Antineoplastics)IBA
11/2017 - 08/2016

Therapy/Procedure

47Therapeutics
03/2024 - 06/2014
16Drug Therapy (Chemotherapy)
08/2021 - 02/2010
15Immunotherapy
09/2023 - 01/2018
11Lasers (Laser)
01/2021 - 12/2015
11Photothermal Therapy
01/2021 - 07/2016
8Phototherapy (Light Therapy)
08/2020 - 12/2015
3Combination Drug Therapy (Combination Chemotherapy)
10/2018 - 07/2017
2Transplantation
01/2021 - 10/2016
2Photochemotherapy (Photodynamic Therapy)
10/2020 - 01/2019
2Radiotherapy
07/2019 - 04/2010
2Precision Medicine
05/2019 - 08/2016